HMI
About
Who we are?
Mission
Traditions & History
Partnerships
Advisory Council
Giving
Support the HMI now
Applied-Microbiology Programs
Disease-Specific Research Programs
Longevity and Aging Research Program
General support of HMI
Ways to give
Your impact
Naming opportunities
Research
Applied microbiology programs
Bacteriophages as New Human Viral Pathogens
Prion-like Domains in Eukaryotic Viruses
Novel bacterial species
The core human microbiome
Novel Bacterial Pathogens of Humans
Antimicrobial resistance | Sporobiota | Sporobiome
Regulators of the Microbiota (NLGE)
Disease-specific Research Programs
Parkinson’s disease
Alzheimer’s disease
Amyotrophic Lateral Sclerosis
Autism
Multiple sclerosis
Oncology
Type 1 Diabetes
Age-related Infectious Diseases
Antibiotic resistance/Novel Diagnostic Systems
Jewish Research
Other Focus Areas
Longevity and Aging Research Program
Therapeutic Areas
For Scientists
Theories Developed by the HMI
Microbiota diseases
The Pangenome concept
Tetz’s theory of longevity
Maternal Inheritance of the Microbiota
Neurodegenerative diseases theory
Genetic Predisposition in Jewish Population
HMI Database
Kluyvera intestini sp. nov. GT-16
Bacillus sp. VT 712
Acinetobacter sp. nov. VT-511
Bacilli bacteriumgen. nov. sp. nov. VT-13-104
Paenibacillus sp. nov. VT 400
Streptococcus sp. nov. VT 162
Publications
Education
Newsroom
News from the HMI
For Journalists
Contact
Mul-1867, A Drug Candidate For Inhalation Therapy Of Pulmonary Exacerbations Caused By Burkholderia Cepacia Complex In Cystic Fibrosis And Copd Patients
Publications
DOWNLOAD PDF
Theories Developed by the HMI
HMI Database
Publications